Dr. John Cush RheumNow
5 years 5 months ago
“Send a photo with the skin biopsy” - advice to rheumatologists by a dermatopathologist to help with path interpretation. #RNL2021
Great #RNL2021 notes from Dr. Kathryn Dao @KDAO2011
Dr. John Cush RheumNow
5 years 5 months ago
Can Multiple Sclerosis and RA Coexist? What Drugs can be used?
https://t.co/PYFQI7vn3M https://t.co/UQplGREDjf
Dr. John Cush RheumNow
5 years 5 months ago
News Feature: IL-23 Targeting for Enthesitis in Psoriatic Arthritis
Treatment with guselkumab (Tremfya) was effective in resolving enthesitis among patients with psoriatic arthritis (PsA), a post-hoc analysis of two phase III trials found.
https://t.co/a6ypaa6Zxb https://t.co/zdRpZWIPAt
JAMA has published the new recommendation from the US Preventive Services Task Force (USPSTF) stating that screening for vitamin D deficiency is unnecessary and unwarranted in asymptomatic adults.
Dr. John Cush RheumNow
5 years 5 months ago
#RNL2021 notes from Dr. Rachel Tate ( @uptoTate )
Clinical pearl: Bisphosphonates can cause posterior iritis (consider this in patients with negative labs and long term use of bisphosphonates.) Dr. Wang
#RheumNow
Dr. John Cush RheumNow
5 years 5 months ago
Artificial intelligence study shows neural networks can be trained to detect radiographic sacroiliitis on pelvic Xrays and achieve expert-level detection of definite radiographic sacroiliitis & could improve diagnostic accuracy at non-specialised sites https://t.co/oLNzWjHjrw
Dr. John Cush RheumNow
5 years 5 months ago
News Feature: Low Risk of Malignancy with Secukinumab
Analysis of ongoing safety from the SEC drug development program shows a low risk for malignancy in SEC patients treated for up to five years for either psoriasis, PsA or AS.
https://t.co/tf1lWa03tF https://t.co/Ad1fOJZv4c
In the United Kingdom, where it is estimated that chronic pain affects one‑third to one‑half of the population, NICE (National Institute for Health and Care Excellence) has recently released an updated guideline on the management of chronic pain for people aged 16 years and over. This document is evidence based and unique in differing from US and Canadian guidelines on pain.
Dr. John Cush RheumNow
5 years 5 months ago
In millions with hand OA, the thumb base (CMC1) is the most affected joint. metanalysis of 16 studies shows Xray CMC1 OA is more prevalent in females and is strongly associated with age. https://t.co/mNeXbWHdwa
Dr. John Cush RheumNow
5 years 5 months ago
News Feature: DMARD Dropouts During COVID-19
Rheumatologists are still seeing the consequences of COVID, with many patients avoiding usual care, follow-up visits, routine lab testing and with many self-stopping their antirheumatic meds.
https://t.co/gwtfvR9o53 https://t.co/92APJKUs0W
Have you wondered why fibromyalgia, fatigue or cognitive dysfunction often co-associate with chronic sinusitis?
Treatment with guselkumab (Tremfya) was effective in resolving enthesitis among patients with psoriatic arthritis (PsA), a post-hoc analysis of two phase III trials found.
Dr. John Cush RheumNow
5 years 5 months ago
Since the COVID vaccine rollout, more people have been eligible to receive the vaccine. However, not everyone chooses to get one. I have heard many reasons from my patients who are vaccine hesitant.
Read more from Dr. Kathryn Dao ( @KDAO2011 )
https://t.co/f5gwBICEGy https://t.co/XgW6wVgo0F
Dr. John Cush RheumNow
5 years 5 months ago
Hopkins Lupus Cohort (1168 patients) followed 24 months shows disease activity (measured by SELENA SLEDAI) increased risk of death (HR=1.22), renal damage (HR=1.24) & CV Dz (HR=1.17); But HCQ reduced death (HR=0.46) https://t.co/zBfitPV5Bl
Dr. John Cush RheumNow
5 years 5 months ago
#RNL2021 takeaways from @KDAO2011
""Liver damage is not an extra-articular manifestation of RA!"" - Dr. S Cohen "
